Prostate cancer is a quiet killer. In most men, it's treatable. However, in some cases, it resists all known therapies and ...
When mice with prostate cancer are given menadione, it messes with the cancer's survival processes. Trotman's team has ...
Dietary pro-oxidant therapy by a vitamin K precursor targets PI 3-kinase VPS34 function - ...
Research reveals how antibodies affect brain receptors in patients with anti-NMDAR encephalitis, a condition often ...
When mice with prostate cancer are given menadione, it messes with the cancer’s survival processes. Trotman’s team has ...
A new study from Cold Spring Harbor Laboratory Professor Lloyd Trotman and colleagues, published in Science, shows that menadione significantly slows prostate cancer growth in mice and in ...
A POPULAR vitamin, vital for bone health, has been shown to significantly slow one of the world’s most common cancers. Prostate cancer affects one in seven men worldwide – in the UK ...
Incyte announced today that for the seventh consecutive year, it has been named a top five biotech and pharma employer based on Science magazine's annual survey. This year, Incyte was ranked third and ...
However, in some cases, it resists all known therapies and turns extremely deadly. A new discovery at Cold Spring Harbor Laboratory (CSHL) points to a potentially groundbreaking... at 13:59 World's ...
Mars is often considered a barren wasteland, with its thin atmosphere and intense ultraviolet radiation making the surface ...